Pinkerton JV - Search Results

1

Safety and benefit considerations for menopausal hormone therapy.

Pickar JH, Archer DF, Kagan R, Pinkerton JV, Taylor HS. Pickar JH, et al. Among authors: pinkerton jv. Expert Opin Drug Saf. 2017 Aug;16(8):941-954. doi: 10.1080/14740338.2017.1343298. Epub 2017 Jun 30. Expert Opin Drug Saf. 2017. PMID: 28664754 Review.

2

Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy.

Santen RJ, Pinkerton J, McCartney C, Petroni GR. Santen RJ, et al. J Clin Endocrinol Metab. 2001 Jan;86(1):16-23. doi: 10.1210/jcem.86.1.7269. J Clin Endocrinol Metab. 2001. PMID: 11231971 Review. No abstract available.

3

Relief of vasomotor symptoms and vaginal atrophy with lower doses of conjugated equine estrogens and medroxyprogesterone acetate.

Utian WH, Shoupe D, Bachmann G, Pinkerton JV, Pickar JH. Utian WH, et al. Among authors: pinkerton jv. Fertil Steril. 2001 Jun;75(6):1065-79. doi: 10.1016/s0015-0282(01)01791-5. Fertil Steril. 2001. PMID: 11384629 Free article. Clinical Trial.

4

Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society.

Utian WH, Archer DF, Bachmann GA, Gallagher C, Grodstein Fn, Heiman JR, Henderson VW, Hodis HN, Karas RH, Lobo RA, Manson JE, Reid RL, Schmidt PJ, Stuenkel CA; North American Menopause Society. Utian WH, et al. Menopause. 2008 Jul-Aug;15(4 Pt 1):584-602. doi: 10.1097/gme.0b013e31817b076a. Menopause. 2008. PMID: 18580541 Free PMC article.

5

Bazedoxifene, a selective estrogen receptor modulator: effects on the endometrium, ovaries, and breast from a randomized controlled trial in osteoporotic postmenopausal women.

Archer DF, Pinkerton JV, Utian WH, Menegoci JC, de Villiers TJ, Yuen CK, Levine AB, Chines AA, Constantine GD. Archer DF, et al. Among authors: pinkerton jv. Menopause. 2009 Nov-Dec;16(6):1109-15. doi: 10.1097/gme.0b013e3181a818db. Menopause. 2009. PMID: 19543129 Clinical Trial.

6

Bazedoxifene effects on the reproductive tract in postmenopausal women at risk for osteoporosis.

Pinkerton JV, Archer DF, Utian WH, Menegoci JC, Levine AB, Chines AA, Constantine GD. Pinkerton JV, et al. Menopause. 2009 Nov-Dec;16(6):1102-8. doi: 10.1097/gme.0b013e3181a816be. Menopause. 2009. PMID: 19546825 Clinical Trial.

7

Relief of vasomotor symptoms with the tissue-selective estrogen complex containing bazedoxifene/conjugated estrogens: a randomized, controlled trial.

Pinkerton JV, Utian WH, Constantine GD, Olivier S, Pickar JH. Pinkerton JV, et al. Menopause. 2009 Nov-Dec;16(6):1116-24. doi: 10.1097/gme.0b013e3181a7df0d. Menopause. 2009. PMID: 19546826 Clinical Trial.

8

Advances in the treatment of menopausal symptoms.

Pinkerton JV, Stovall DW, Kightlinger RS. Pinkerton JV, et al. Womens Health (Lond). 2009 Jul;5(4):361-384; quiz 383-4. doi: 10.2217/whe.09.31. Womens Health (Lond). 2009. PMID: 19586429 Free article. Review.

9

Evaluation of bazedoxifene/conjugated estrogens for the treatment of menopausal symptoms and effects on metabolic parameters and overall safety profile.

Lobo RA, Pinkerton JV, Gass MLS, Dorin MH, Ronkin S, Pickar JH, Constantine G. Lobo RA, et al. Among authors: pinkerton jv. Fertil Steril. 2009 Sep;92(3):1025-1038. doi: 10.1016/j.fertnstert.2009.03.113. Epub 2009 Jul 26. Fertil Steril. 2009. PMID: 19635615 Free article. Clinical Trial.

10

Menstrual cycle-related exacerbation of disease.

Pinkerton JV, Guico-Pabia CJ, Taylor HS. Pinkerton JV, et al. Am J Obstet Gynecol. 2010 Mar;202(3):221-31. doi: 10.1016/j.ajog.2009.07.061. Am J Obstet Gynecol. 2010. PMID: 20207238 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page